Finding Opportunities in the Generic Neurology Drug Sector

(Nashua, NH) – In terms of medical specialty segments, neurology represents one of the broadest and deepest drug therapy markets. The convergence of evolution in healthcare technology and refinements in prescribing trends for non-pathological conditions continue to advance this segment. It has been and continues to be one of the two most active medical specialties for generic drug marketers.

Currently the generic neurology drug sector is comprised of 203 APIs representing 40 therapeutic classes. These drugs are supported by 2,380 unique ANDAs. At the product dosage level, the number expands to a grand total of 6,900 unique generic drug products.

More than three hundred companies compete in the generic neurology segment. At the individual competitor level, about one-third of ANDA applicants account for at least ten generic neurology drug APIs. More than half of the suppliers in the generic neurology segment are listed as ANDA applicants for four APIs or fewer.

Our analysis into these numbers exposes the underlying product landscape and relative activity levels across therapeutic classes and reveals a number of segments that represent potential opportunities for generic drug suppliers. As expected, these classes are highly competitive with numerous suppliers. However, the competitive intensity at the dosage level demonstrates uneven competition. Successfully identifying dosage levels for specific generics that may be underserved and thus represent growth potential requires a comprehensive assessment of disease prevalence and prescribing trends, but can be an attractive option in the highly competitive neurology generics market.

These findings are contained in a comprehensive report researched and written by Applied Market Data. Generic Neurology Drugs has been researched and written to provide market participants and stakeholders with a comprehensive analysis of the products, therapeutic segments, competitive landscape and market scope in this evolving generic drug segment.

More information is available at www.appliedmarketdata.com


Source: Applied Market Data

About Applied Market Data

Applied Market Data is a consulting firm focused on the generic drug sector. We assist companies in achieving their business objectives through the creation of decision support information tools and market research and analysis. Our publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and achieve their financial targets.

Contact:

Greg Stone
Applied Market Data
98 Amherst Street
Amherst, NH 03031 USA
Voice: 603-341-3073
grstone@appliedmarketdata.com
www.appliedmarketdata.com

This release was published on openPR.